Optimizing Mycophenolate Therapy in Renal Transplant Patients Using Machine Learning and Population Pharmacokinetic Modeling
Medical Sciences · 20.10.2025 · 13 (4) · 235
DOI: 10.3390/medsci13040235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Sciences, online erschienen am 20.10.2025. Verfasst von Anastasia Tsyplakova und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Health Science, National and Kapodistrian University of Athens, 15784 Athens, Greece. Hauptthemen laut MEDLINE: Mycophenolic Acid, Kidney Transplantation, Machine Learning, Immunosuppressive Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Mycophenolic acid (MPA) is used as part of first-line combination immunosuppressive therapy for renal transplant recipients. Personalized dosing approaches are needed to balance efficacy and minimize toxicity due to the pharmacokinetic variability of the drug. In this study, population pharmacokinetic (PopPK) modeling and machine learning (ML) techniques are coupled to provide valuable insights into optimizing MPA therapy.
Methods
Using data from 76 renal transplant patients, two PopPK models were developed to describe and predict MPA levels for two different formulations (enteric-coated mycophenolate sodium and mycophenolate mofetil). Covariate effects on drug clearance were assessed, and Monte Carlo simulations were used to evaluate exposure under normal and reduced clearance conditions. ML techniques, including principal component analysis (PCA) and ensemble tree models (bagging and boosting), were applied to identify predictive factors and explore associations between MPA plasma/saliva concentrations and the examined covariates.
Results
Total daily dose and post-transplant time (PTP) were identified as key covariates affecting clearance. PCA highlighted MPA dose as the primary determinant of plasma levels, with urea and PTP also playing significant roles. Boosted tree analysis confirmed these findings, demonstrating strong predictive accuracy (R2 > 0.91). Incorporating saliva MPA levels improved predictive performance, suggesting that saliva may be a complementary monitoring tool, although plasma monitoring remained superior. Simulations allowed exploring potential dosing adjustments for patients with reduced clearance.
Conclusions
This study demonstrates the potential of integrating machine learning with population pharmacokinetic modeling to improve the understanding of MPA variability and support individualized dosing strategies in renal transplant recipients. The developed PopPK/ML models provide a methodological foundation for future research toward more personalized immunosuppressive therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Health Science, National and Kapodistrian University of Athens, 15784 Athens, Greece.
- Department of Pharmacy, Faculty of Medicine, University of Nis, 18000 Nis, Serbia.
ORCID-Profile: Anastasia Tsyplakova, Aleksandra Catic-Djorđevic, Nikola Stefanović, Vangelis D Karalis
Zitieren
APA
Tsyplakova, A., Catic-Djorđevic, A., Stefanović, N., & Karalis, V. D. (2025). Optimizing Mycophenolate Therapy in Renal Transplant Patients Using Machine Learning and Population Pharmacokinetic Modeling. Medical Sciences, 13(4), 235. https://doi.org/10.3390/medsci13040235
Vancouver
Tsyplakova A, Catic-Djorđevic A, Stefanović N, Karalis VD. Optimizing Mycophenolate Therapy in Renal Transplant Patients Using Machine Learning and Population Pharmacokinetic Modeling. Medical Sciences. 2025;13(4):235. doi:10.3390/medsci13040235
BibTeX
@article{Tsyplakova2025,
author = {Tsyplakova, Anastasia and Catic-Djorđevic, Aleksandra and Stefanović, Nikola and Karalis, Vangelis D},
title = {Optimizing Mycophenolate Therapy in Renal Transplant Patients Using Machine Learning and Population Pharmacokinetic Modeling},
journal = {Medical Sciences},
year = {2025},
volume = {13},
number = {4},
pages = {235},
doi = {10.3390/medsci13040235}
}
EUVIMED